Eleusis

About:

Eleusis is a Clinical stage company established to unlock the therapeutic potential of psychedelics.

Top Investors: Noetic Fund, Palo Santo Fund

Description:

Eleusis is a clinical stage life science company dedicated to unlocking the therapeutic potential of serotonin 2A receptor agonists, commonly referred to as psychedelics, through the mitigation and management of psychoactivity

Total Funding Amount:

$5.74M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2013-01-01

Contact Email:

contact(AT)eleusisltd.com

Founders:

Shlomi Raz

Number of Employees:

11-50

Last Funding Date:

2020-10-01

IPO Status:

Private

Industries: